Submit a manuscript Sign up for article alerts Contact us Support

About Mobile DNA

This page includes information about the aims and scope of Mobile DNA, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Mobile DNA is an online, peer-reviewed, open access journal that publishes articles providing novel insights into DNA rearrangements in all organisms, ranging from transposition and other types of recombination mechanisms to patterns and processes of mobile element and host genome evolution.

In addition, the journal will consider articles on the utility of mobile genetic elements in biotechnological methods and protocols. Articles on microorganisms and viruses are particularly welcome.

Mobile DNA aims to understand:

  • mechanisms of recombination using genetic, biochemical and structural approaches
  • regulation of DNA rearrangements by the environment and during development
  • how DNA rearrangements affect cellular function and organism evolution
  • mechanisms of host—element interaction

Mobile DNA reflects the need for a journal that spans all aspects of specialized recombination, from evolutionary impact to structure and mechanism. Manuscripts describing DNA rearrangements such as copy number variation are also welcome.

Open access

All articles published by Mobile DNA are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Mobile DNA are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Mobile DNA therefore levies an article-processing charge of £1520/$2545/€1835 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

Indexing services

All articles published in Mobile DNA are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Mobile DNA include:

  • CAS
  • Citebase
  • DOAJ
  • Google Scholar
  • Index Copernicus
  • OAIster
  • PubMed
  • PubMed Central
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in Mobile DNA will be available.

Publication and peer review process

Content overview

Research: reports of data from original research.

Reviews: comprehensive, authoritative, descriptions of any subject within the journal’s scope.

Methodology: presentations of a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article should describe a demonstrable advance on what is currently available.

Short reports: brief reports of data from original research.

Commentaries: short, narrowly focused articles of contemporary interest. These are usually commissioned by the journal.

Book reviews: summaries of the strengths and weaknesses of a book. They evaluate the book's overall usefulness to the intended audience.

Meeting reports: a short description of a conference that the author has attended, which focuses on the key developments presented and discussed at the meeting.

Software: describe the source code for software applications, tools or algorithm implementations. Typically, an archive of the source code of the current version of the software should be included with the submitted manuscript as a supplementary file.

Peer-review policies

All manuscripts are reviewed by internationally recognized experts in the field, selected in part from our Editorial Board. Reviews are rapid and the suitability of a manuscript for publication is assessed solely on criteria of scientific excellence. Final decisions are made by the Editors-in-Chief.

Edited by Nancy Craig, Thomas Eickbush, Cédric Feschotte and Henry Levin, Mobile DNA is supported by an expert Editorial Board.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Mobile DNA, a personalized section of the site.

Copyediting and proofs

All articles published in Mobile DNA are copyedited before publication of the final version.

Articles published in Mobile DNA are published immediately on acceptance in the form of a provisional PDF. Copyedited and fully formatted PDF and full-text (HTML) versions are made available shortly after that.

Edited versions will be sent by email and corrections should be returned within two working days. Please provide a typed list of corrections clearly indicating where the corrections should be made and please send this list by email.

The editing is designed only to correct such things as misused words, spelling errors, missing references or incomplete citation information.

Reprints

High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.

Supplements

Mobile DNA will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to Mobile DNA should adhere to BioMed Central's editorial policies.

Citing articles in Mobile DNA

Articles in Mobile DNA should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Mobile DNA [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Mobile DNA 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Mobile DNA?

High visibility

Mobile DNA's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Mobile DNA offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Mobile DNA, BioMed Central and PubMed Central and will also be included in PubMed.

Flexibility

Online publication in Mobile DNA gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Mobile DNA are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Mobile DNA's pages and on the BioMed Central homepage.

In addition, articles published in Mobile DNA may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Mobile DNA. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in Mobile DNA retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.